Tong Li

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Neoadjuvant Chemotherapy

Sentinel Lymph Node

Ejection Fraction

Top Venues

Pharmaceuticals (Basel, Switzerland)

Cancer cell international

This page only lists publications with an associated author ORCID identifier.

Publications

Tong Li, Yu Xu, Wei Sun, Wangjun Yan, Chunmeng Wang, Tu Hu, Xiaowei Zhang, Zhiguo Luo, Xin Liu, Yong Chen
Adjuvant Anti-PD-1 Immunotherapy versus Conventional Therapy for Stage III Melanoma: A Real-World Retrospective Cohort Study. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Tong Li, Yu Xu, Wei Sun, Wangjun Yan, Chunmeng Wang, Tu Hu, Xiaowei Zhang, Zhiguo Luo, Xin Liu, Yong Chen
Adjuvant Anti-PD-1 Immunotherapy versus Conventional Therapy for Stage III Melanoma: A Real-World Retrospective Cohort Study. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Tong Li, Yu Xu, Wei Sun, Wangjun Yan, Chunmeng Wang, Tu Hu, Xiaowei Zhang, Zhiguo Luo, Xin Liu, Yong Chen
Adjuvant Anti-PD-1 Immunotherapy versus Conventional Therapy for Stage III Melanoma: A Real-World Retrospective Cohort Study. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Tong Li, Yu Xu, Wei Sun, Wangjun Yan, Chunmeng Wang, Tu Hu, Xiaowei Zhang, Zhiguo Luo, Xin Liu, Yong Chen
Adjuvant Anti-PD-1 Immunotherapy versus Conventional Therapy for Stage III Melanoma: A Real-World Retrospective Cohort Study. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Tong Li, Qiaofei Liu, Ronghua Zhang, Quan Liao, Yupei Zhao
Correction to: Identification of prognosis-related genes and construction of multi-regulatory networks in pancreatic cancer microenvironment by bioinformatics analysis. Cancer cell international 20 (2020)
Tong Li, Qiaofei Liu, Ronghua Zhang, Quan Liao, Yupei Zhao
Identification of prognosis-related genes and construction of multi-regulatory networks in pancreatic cancer microenvironment by bioinformatics analysis. Cancer cell international 20 (2020)